B型肝炎用治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3779)
◆英語タイトル:Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3779
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、B型肝炎用治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他)、用途別市場規模(病院薬局、小売薬局&ドラッグストア、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・B型肝炎用治療薬の市場動向
・企業の競争状況、市場シェア
・B型肝炎用治療薬の種類別市場規模(エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他)
・B型肝炎用治療薬の用途別市場規模(病院薬局、小売薬局&ドラッグストア、その他)
・B型肝炎用治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・B型肝炎用治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・B型肝炎用治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・B型肝炎用治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・B型肝炎用治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(GlaxoSmithKline、Bristol-Myers Squibb、Mitsubishi Tanabe Pharma、Johnson & Johnson、Roche、Gilead Sciences、Merck & Co. Inc.、Novartis、AbbVie)
・結論
【レポートの概要】

Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver.

Market Analysis and Insights: Global Hepatitis B Therapeutic Drug Market
The global Hepatitis B Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B Therapeutic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B Therapeutic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B Therapeutic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B Therapeutic Drug market.

Global Hepatitis B Therapeutic Drug Scope and Market Size
Hepatitis B Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Entecavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Bristol-Myers Squibb
Mitsubishi Tanabe Pharma
Johnson & Johnson
Roche
Gilead Sciences
Merck & Co. Inc.
Novartis
AbbVie

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 Lamivudine
1.2.5 Adefovir
1.2.6 Telbivudine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hepatitis B Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies & Drug Stores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis B Therapeutic Drug Market Perspective (2016-2027)
2.2 Hepatitis B Therapeutic Drug Growth Trends by Regions
2.2.1 Hepatitis B Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B Therapeutic Drug Industry Dynamic
2.3.1 Hepatitis B Therapeutic Drug Market Trends
2.3.2 Hepatitis B Therapeutic Drug Market Drivers
2.3.3 Hepatitis B Therapeutic Drug Market Challenges
2.3.4 Hepatitis B Therapeutic Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Therapeutic Drug Players by Revenue
3.1.1 Global Top Hepatitis B Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B Therapeutic Drug Revenue
3.4 Global Hepatitis B Therapeutic Drug Market Concentration Ratio
3.4.1 Global Hepatitis B Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Therapeutic Drug Revenue in 2020
3.5 Hepatitis B Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Hepatitis B Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Hepatitis B Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis B Therapeutic Drug Breakdown Data by Type
4.1 Global Hepatitis B Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B Therapeutic Drug Forecasted Market Size by Type (2022-2027)

5 Hepatitis B Therapeutic Drug Breakdown Data by Application
5.1 Global Hepatitis B Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B Therapeutic Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis B Therapeutic Drug Market Size (2016-2027)
6.2 North America Hepatitis B Therapeutic Drug Market Size by Type
6.2.1 North America Hepatitis B Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Hepatitis B Therapeutic Drug Market Size by Application
6.3.1 North America Hepatitis B Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Hepatitis B Therapeutic Drug Market Size by Country
6.4.1 North America Hepatitis B Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hepatitis B Therapeutic Drug Market Size (2016-2027)
7.2 Europe Hepatitis B Therapeutic Drug Market Size by Type
7.2.1 Europe Hepatitis B Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Hepatitis B Therapeutic Drug Market Size by Application
7.3.1 Europe Hepatitis B Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Hepatitis B Therapeutic Drug Market Size by Country
7.4.1 Europe Hepatitis B Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis B Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Hepatitis B Therapeutic Drug Market Size by Type
9.2.1 Latin America Hepatitis B Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B Therapeutic Drug Market Size by Application
9.3.1 Latin America Hepatitis B Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B Therapeutic Drug Market Size by Country
9.4.1 Latin America Hepatitis B Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Hepatitis B Therapeutic Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Hepatitis B Therapeutic Drug Introduction
11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Company Details
11.3.2 Mitsubishi Tanabe Pharma Business Overview
11.3.3 Mitsubishi Tanabe Pharma Hepatitis B Therapeutic Drug Introduction
11.3.4 Mitsubishi Tanabe Pharma Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.3.5 Mitsubishi Tanabe Pharma Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Hepatitis B Therapeutic Drug Introduction
11.4.4 Johnson & Johnson Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Hepatitis B Therapeutic Drug Introduction
11.5.4 Roche Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences Hepatitis B Therapeutic Drug Introduction
11.6.4 Gilead Sciences Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.6.5 Gilead Sciences Recent Development
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Details
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Hepatitis B Therapeutic Drug Introduction
11.7.4 Merck & Co. Inc. Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.7.5 Merck & Co. Inc. Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Hepatitis B Therapeutic Drug Introduction
11.8.4 Novartis Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Hepatitis B Therapeutic Drug Introduction
11.9.4 AbbVie Revenue in Hepatitis B Therapeutic Drug Business (2016-2021)
11.9.5 AbbVie Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ B型肝炎用治療薬の世界市場規模・現状・予測2021年-2027年(Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。